ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
Holding IMUC?
Track your performance easily

ImmunoCellular Therapeutics (IMUC) Cash flow

180 Followers

ImmunoCellular Therapeutics Cash Flow

IMUC's free cash flow for Q2 2018 was $-2.17M. For the 2018 fiscal year, IMUC's free cash flow was decreased by $3.20M and operating cash flow was $-2.17M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 17Dec 16Dec 15Dec 14Dec 13
Operating Cash Flow
$ -10.93M$ -16.67M$ -19.86M$ -19.04M$ -9.94M$ -8.79M
Investing Cash Flow
$ 1.33K$ 1.33K$ -4.01K$ -169.75K$ -28.57K$ -44.37K
Financing Cash Flow
$ 11.96M$ 11.86M$ 8.70M$ 18.59M$ 5.54M$ 10.26M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 20.51M$ 6.63M$ 11.44M$ 22.60M$ 23.22M$ 27.65M
Income Tax Paid Supplemental Data
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Issuance Of Capital Stock
$ 4.05M$ 4.05M$ 7.04M$ 14.60M$ 4.50M$ 4.91M
Issuance Of Debt
-----$ 0.00
Repayment Of Debt
------
Free Cash Flow
$ -10.93M$ -16.67M$ -19.87M$ -19.21M$ -9.97M$ -8.83M
Domestic Sales
------
Foreign Sales
------
Currency in USD

ImmunoCellular Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis